Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Epilepsia

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/epi.13639PMID 28012175
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of antiepileptic drugs for the treatment of Dravet syndrome with different genotypes.

  2016cited by this paper
• Dravet syndrome in Sweden: a population‐based study

  2015cited by this paper
• Incidence of Dravet Syndrome in a US Population

  2015cited by this paper
• Incidence of Dravet Syndrome in a US Population

  2015cited by this paper
• The SCN1A Mutation Database: Updating Information and Analysis of the Relationships among Genotype, Functional Alteration, and Phenotype

  2015influential reference
• The incidence of SCN1A‐related Dravet syndrome in Denmark is 1:22,000: A population‐based study from 2004 to 2009

  2015cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• CACNA1A variants may modify the epileptic phenotype of Dravet syndrome.

  2013cited by this paper
• Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome.

  2012influential reference
• Jasper's basic mechanisms of the epilepsies

  2012cited by this paper
• Sodium Channel Mutations and Epilepsy

  2012cited by this paper
• [Genetic and phenotypic characteristics of SCN1A mutations in Dravet syndrome].

  2012influential reference
• Mosaic SCN1A mutations in familial partial epilepsy with antecedent febrile seizures

  2012cited by this paper
• Cognitive development in Dravet syndrome: A retrospective, multicenter study of 26 patients

  2011cited by this paper
• Genotype–phenotype associations in SCN1A-related epilepsies

  2011cited by this paper
• Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study.

  2010cited by this paper
• Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects

  2010influential reference
• Variable epilepsy phenotypes associated with a familial intragenic deletion of the SCN1A gene

  2010cited by this paper
• Stiripentol open study in Japanese patients with Dravet syndrome

  2009cited by this paper
• Introducing sense into nonsense in treatments of human genetic diseases.

  2008cited by this paper
• Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients

  2008influential reference
• The spectrum of SCN1A-related infantile epileptic encephalopathies.

  2007cited by this paper
• Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease

  2006influential reference
• SCN1A mutations and epilepsy

  2005cited by this paper
• Mutations of sodium channel alpha subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures.

  2003cited by this paper
• Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy.

  2002cited by this paper
• Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2

  2000cited by this paper
• Early diagnosis of severe myoclonic epilepsy in infancy.

  1992cited by this paper
• Epidemiology of Severe Myoclonic Epilepsy of Infancy

  1990cited by this paper
• A genetic study of febrile convulsions.

  1982cited by this paper
• Les epilepsies graves de l'enfant

  1978cited by this paper
• A genetic study of febrile convulsions

  1970cited by this paper

• Expanding the Genetic and Clinical Spectrum of SCN1A-Related Hemiplegic Migraine: Analysis of Mutations in Japanese

  2025cites this paper
• A case of Dravet syndrome with a novel SCN1A gross deletion involving the promoter region

  2025cites this paper
• Nonseizure Outcomes in Dravet Syndrome: Potential Impact of Pharmacotherapy

  2025cites this paper
• Depolarization block induction via slow NaV1.1 inactivation in Dravet syndrome

  2025influential citation
• A systematic literature review on the global epidemiology of Dravet syndrome and Lennox–Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality

  2024cites this paper
• Genotype–phenotype associations in 1018 individuals with SCN1A‐related epilepsies

  2024cites this paper
• Impact of variant subtype on electro-clinical phenotype of Dravet syndrome- a South Indian cohort study.

  2024cites this paper
• Association of genetic variants with autism spectrum disorder in Japanese children revealed by targeted sequencing

  2024cites this paper
• The Therapeutic Role of Perampanel in Treating Pediatric Patients With Dravet Syndrome: A Scoping Review

  2024cites this paper
• SCN1A: bioinformatically informed revised boundaries for promoter and enhancer regions

  2023cites this paper
• Bi-allelic variants in NAE1 cause intellectual disability, ischiopubic hypoplasia, stress-mediated lymphopenia and neurodegeneration.

  2023cites this paper
• Caregiver reported behavior, sleep and quality of life in children with Dravet syndrome: A population-based study.

  2023cites this paper
• Inherited SCN1A missense mutation in a Dravet Syndrome family: Neuropathological correlation, family screening and implications for adult carriers.

  2023cites this paper
• Deciphering the impact of coding and non-coding SCN1A gene variants on RNA splicing.

  2023cites this paper
• Anesthetic management of a pediatric patient with Dravet syndrome: A case report

  2023cites this paper
• A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

  2022cites this paper
• Dravet syndrome in children - a population-based studyEpilepsy in Dravet syndrome Dravet syndrome in children - a population-based study

  2022influential citation
• Genetics of Dravet Syndrome and its Targeted Therapy by Nanomedicine: A Roadmap for Future Treatment of Drug Resistant Seizures.

  2022cites this paper
• SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility

  2022cites this paper
• Dravet syndrome in children-A population-based study.

  2022cites this paper
• Molecular mechanisms of topiramate and its clinical value in epilepsy.

  2022cites this paper
• The clinical, economic, and humanistic burden of Dravet syndrome - A systematic literature review.

  2022cites this paper
• Clinical and Functional Features of Epilepsy-Associated In-Frame Deletion Variants in SCN1A

  2022cites this paper
• Genetic Landscape of SCN1A Variants in a Turkish Cohort with GEFS+ Spectrum and Dravet Syndrome

  2022cites this paper
• The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.

  2022cites this paper
• SCN1A-assoziierte Epilepsie mit foudroyantem Verlauf: Nicht immer muss die Langzeitprognose schlecht sein!

  2021cites this paper
• Genetics and gene therapy in Dravet syndrome.

  2021cites this paper
• Evaluation of spontaneous seizure activity, sex-dependent differences, behavioral comorbidities, and alterations in CA1 neuron firing properties in a mouse model of Dravet Syndrome

  2021cites this paper
• Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy

  2021cites this paper
• Long-term Efficacy of Perampanel in a Child with Dravet Syndrome

  2021cites this paper
• Guidance on Dravet syndrome from infant to adult care: Road map for treatment planning in Europe

  2021cites this paper
• SCN1A mutation spectrum in a cohort of Bulgarian patients with GEFS+ phenotype.

  2020cites this paper
• High genetic burden in 163 Chinese children with status epilepticus.

  2020cites this paper
• Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy

  2020cites this paper
• Variable patterns of mutation density among NaV1.1, NaV1.2 and NaV1.6 point to channel-specific functional differences associated with childhood epilepsy

  2020cites this paper
• Cognitive, behavioral, and social functioning in children and adults with Dravet syndrome.

  2020cites this paper
• Application of Induced Pluripotent Stem Cells in Epilepsy.

  2020cites this paper
• Intellectual functioning and behavior in Dravet syndrome: A systematic review.

  2020cites this paper
• Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application

  2020cites this paper
• Complex epilepsy: it’s all in the history

  2020cites this paper
• [Difficulties in the diagnosis, prognosis and treatment of genetic epileptic encephalopathies: the view of a neurologist].

  2019cites this paper
• Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies

  2019cites this paper
• Adolescent behavioral abnormalities in a Scn1a+/- mouse model of Dravet syndrome.

  2019cites this paper
• A single-center, retrospective analysis of genotype-phenotype correlations in children with Dravet syndrome.

  2019cites this paper
• Klinische Charakteristika, Ressourcenverbrauch, Lebensqualität und Versorgungssituation beim Dravet-Syndrom in Deutschland

  2019cites this paper
• SCN1B and SCN2B gene variants analysis in dravet syndrome patients

  2019cites this paper
• Anesthetic Management of Patient With Dravet Syndrome: A Case Report.

  2019cites this paper
• Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy

  2019cites this paper
• Genetic and phenotypic characteristics of SCN1A-related epilepsy in Chinese children

  2019cites this paper
• [18F]fluorodeoxyglucose-positron emission tomography study of genetically confirmed patients with Dravet syndrome

  2018cites this paper
• The voltage-gated channelopathies as a paradigm for studying epilepsy-causing genes

  2018cites this paper
• Genetic Defects of Voltage-Gated Sodium Channel α Subunit 1 in Dravet Syndrome and the Patients’ Response to Antiepileptic Drugs

  2018cites this paper
• Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes

  2018cites this paper
• Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.

  2018cites this paper
• Genetic Background of Encephalopathy

  2018cites this paper
• From molecules to medicines: the dawn of targeted therapies for genetic epilepsies

  2018cites this paper
• The Problem of Rarity: Estimation of Prevalence in Rare Disease.

  2018cites this paper
• Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome

  2017cites this paper
• WITHDRAWN: Genetics update: Monogenetics, polygene disorders and the quest for modifying genes.

  2017cites this paper
• Genetics update: Monogenetics, polygene disorders and the quest for modifying genes

  2017cites this paper
• Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations

  2017cites this paper